23价肺炎疫苗联合流感疫苗接种对慢性阻塞性肺疾病影响的Meta分析
Meta-Analysis of the Effect of 23 Valent Pneumonic Vaccine Combined with Influenza Vaccine on Chronic Obstructive Pulmonary Disease
DOI: 10.12677/ACM.2022.127971, PDF,   
作者: 李钰婵, 戚 萌, 梁 楠:西安医学院,陕西 西安;杨淑梅, 张 薇*:陕西省人民医院呼吸与危重症医学科,陕西 西安;兀 威:西安医学院第二附属医院呼吸与危重症医学科,陕西 西安
关键词: 23价肺炎球菌多糖疫苗流感疫苗慢性阻塞性肺疾病Meta分析23-Valent Pneumococcal Polysaccharide Vaccine Influenza Vaccine Chronic Obstructive Pulmonary Disease Meta Analysis
摘要: 目的:比较23价肺炎球菌多糖疫苗、流感疫苗联合接种和常规治疗对慢性阻塞性肺疾病(Chronic Obstructive Pulmonary Disease COPD)患者的临床防治效果。方法:检索时间从各数据库建库时间至2022年6月的中英文数据库。阅读相关文献,根据纳入与排除标准筛选文献提取资料,对文献质量进行评价,采用RevMan5.4软件进行分析。结果:共纳入12篇文献,1416个研究对象,其中干预组占699个,对照组717个。进行荟萃分析后结果显示,23价肺炎球菌疫苗联合流感疫苗可缩短COPD患者平均住院天数(WMD = −4.35, 95% CI = −4.50~−4.21, P < 0.00001)、减少COPD急性发作次数(WMD = −4.31, 95% CI = −4.46~−4.17, P < 0.00001)、降低COPD患者全因死亡风险(RR = 0.23, 95% CI = 0.14~0.38, P < 0.00001)。结论:23价肺炎球菌多糖疫苗与流感疫苗的联合接种对于减少COPD患者的急性发作次数、降低死亡风险、缩短住院天数有着积极作用;但是由于方法学原因及文献质量高低不一,需要更多科学、严谨、质量高的研究验证疫苗联合接种效果。
Abstract: Objective: To compare the clinical prevention and treatment effects of 23 valent pneumococcal pol-ysaccharide vaccine combined with influenza vaccine and routine treatment on patients with chronic obstructive pulmonary disease (COPD). Methods: Related literatures were read from Chi-nese and English databases from the establishment time of each database to June 2022. The litera-tures were screened and extracted according to inclusion and exclusion criteria, and the literature quality was evaluated. RevMan5.4 software was used for analysis. Results: A total of 1416 subjects were included in 12 studies, including 699 in the intervention group and 717 in the control group. Meta-analysis showed that 23-valent pneumococcal vaccine combined with influenza vaccine re-duced the average length of hospital stay in COPD patients (WMD = −4.35, 95% CI = −4.50 to −4.21, P < 0.00001), reduced the number of COPD acute (WMD = −4.31, 95% CI = −4.46~−4.17, P < 0.00001), reduced the risk of all-cause death in COPD patients (RR = 0.23, 95% CI = 0.14~0.38, P < 0.00001). Conclusion: The combined administration of 23 valent pneumococcal polysaccharide vac-cine and influenza vaccine has a positive effect on reducing the number of acute episodes in COPD patients, reducing the risk of death and shortening the length of hospital stay; However, due to methodological reasons and different literature quality, more scientific and rigorous high-quality studies are needed to verify the effect of combined vaccination.
文章引用:李钰婵, 戚萌, 梁楠, 杨淑梅, 兀威, 张薇. 23价肺炎疫苗联合流感疫苗接种对慢性阻塞性肺疾病影响的Meta分析[J]. 临床医学进展, 2022, 12(7): 6731-6739. https://doi.org/10.12677/ACM.2022.127971

参考文献

[1] 慢性阻塞性肺疾病糖皮质激素规范管理撰写组. 慢性阻塞性肺疾病糖皮质激素规范管理专家共识(2021版) [J]. 中华结核和呼吸杂志, 2021, 44(12): 1054-1063.
[2] 魏莉莉, 刘海. 慢性阻塞性肺疾病临床康复循证实践指南[J]. 中国康复理论与实践, 2021, 27(1): 15-26.
[3] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版) [J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
[4] Deguchi, Y., Takasugi, Y. and Tatara, K. (2000) Efficacy of Influenza Vaccine in the Elderly in Welfare Nursing Homes: Reduction in Risks of Mortality and Morbidity during an Influenza A (H3N2) Epi-demic. Journal of Medical Microbiology, 49, 553-556. [Google Scholar] [CrossRef] [PubMed]
[5] Mangtani, P., Cumberland, P., Hodgson, C.R., Roberts, J.A., Cutts, F.T. and Hall, A.J. (2004) A Cohort Study of the Effectiveness of Influenza Vaccine in Older People, Performed Using the United Kingdom General Practice Research Database. The Journal of Infectious Diseases, 190, 1-10. [Google Scholar] [CrossRef] [PubMed]
[6] Nichol, K.L., Nordin, J.D., Nelson, D.B., Mullooly, J.P. and Hak, E. (2007) Effectiveness of Influenza Vaccine in the Community-Dwelling Elderly. The New England Journal of Medicine, 357, 1373-1381. [Google Scholar] [CrossRef
[7] Nichol, K.L. (2005) Influenza Vaccination in the Elderly: Impact on Hospitalisation and Mortality. Drugs & Aging, 22, 495-515. [Google Scholar] [CrossRef] [PubMed]
[8] Maruyama, T., Taguchi, O., Niederman, M.S., Morser, J., Kobayashi, H., Kobayashi, T., D’Alessandro-Gabazza, C., Nakayama, S., Nishikubo, K., Noguchi, T., Takei, Y. and Gabazza, E.C. (2010) Efficacy of 23-Valent Pneumococcal Vaccine in Preventing Pneumonia and Improving Survival in Nursing Home Residents: Double Blind, Randomised and Placebo Controlled Trial. BMJ, 340, c1004. [Google Scholar] [CrossRef] [PubMed]
[9] Mooney, J.D., Weir, A., McMenamin, J., Ritchie, L.D., Macfarlane, T.V., Simpson, C.R., Ahmed, S., Robertson, C. and Clarke, S.C. (2008) The Impact and Effectiveness of Pneumococcal Vac-cination in Scotland for Those Aged 65 and over during Winter 2003/2004. BMC Infectious Diseases, 8, Article No. 53. [Google Scholar] [CrossRef] [PubMed]
[10] 陈薇. 23价肺炎球菌疫苗联合流感疫苗对COPD急性发作的临床干预[J]. 国际医药卫生导报, 2014, 20(12): 1767-1770.
[11] 葛云霞. 23价肺炎球菌多糖疫苗与流感疫苗联合接种对COPD患者的预防和治疗作用[J]. 世界临床医学, 2017, 11(19): 57.
[12] 韩性运, 韩丽丽. 联合疫苗接种对慢性阻塞性肺病患者防治的追踪观察[J]. 中国实用医药, 2011, 6(5): 159-160. [Google Scholar] [CrossRef
[13] 乔萍. 高原地区慢性阻塞性肺疾病患者接种23价肺炎球菌多糖疫苗和流感疫苗的疗效观察[J]. 中国实用医药, 2014, 9(23): 191-192. [Google Scholar] [CrossRef
[14] 孙冬. 23价肺炎球菌多糖疫苗和流感疫苗联合接种对慢性阻塞性肺病患者防治的疗效观察[J]. 中国卫生标准管理, 2016, 7(2): 114-115.
[15] 王学英. 西宁地区慢性阻塞性肺病患者稳定期接种2种疫苗的效果观察[J]. 青海医药杂志, 2010, 40(7): 75-76.
[16] 严祖喜, 杜小勇, 富冯峰, 张飞峰, 张勤俊. 联合疫苗接种对慢性阻塞性肺疾病急性发作的影响[J]. 中国基层医药, 2018, 25(16): 2133-2135.
[17] 余其好, 潘定宏, 许有志. 23价肺炎球菌多糖疫苗和流感疫苗联合接种对慢性阻塞性肺病患者防治的疗效观察[J]. 齐齐哈尔医学院学报, 2008(1): 7-8.
[18] 章琴莺. 流感疫苗和肺炎球菌疫苗预防COPD急性发作疗效观察[J]. 浙江中西医结合杂志, 2014, 24(7): 597-599.
[19] 邓小彬, 宁康. 23价肺炎球菌多糖疫苗接种影响COPD稳定期患者的价值分析[J]. 饮食保健, 2017, 4(26): 94-95. [Google Scholar] [CrossRef
[20] 孔沛良, 张平, 黄潘文. 流感疫苗与肺炎球菌疫苗接种对预防COPD急性发作的疗效分析[J]. 齐齐哈尔医学院学报, 2017, 38(11): 1277-1278.
[21] 梁夫征. 流感疫苗、肺炎球菌疫苗对COPD急性发作的预防作用观察[J]. 健康必读, 2018(3): 91-92.
[22] 蔡柏蔷, 陈荣昌. 慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版) [J]. 国际呼吸杂志, 2017, 37(14): 1041-1057.
[23] Grilli, G., Fuiano, L., Biasio, L.R., Pregliasco, F., Plebani, A., Leibovitz, M., Ugazio, A.G., Vacca, F. and Profeta, M.L. (1997) Simultaneous Influenza and Pneumococcal Vaccination in Elderly Individuals. European Jour-nal of Epidemiology, 13, 287-291. [Google Scholar] [CrossRef